

FreeStyle Libre 2 System
The #1 sensor-based glucose monitoring systems used worldwide1
Learn how patients can meet the three goals of the Triangle of Diabetes Care, keep their Time in Range up, and ultimately, improve clinical outcomes and quality of their life.2,3,4
Explore how the FreeStyle Libre portfolio and digital health solutions connect, to provide you with more insights to better management and outcomes for your diabetes patients.5,6
Designed specifically for Healthcare Professionals, our online education platform will help you in supporting your patients.
The #1 sensor-based glucose monitoring systems used worldwide1
Get the most out of the FreeStyle Libre ecosystem by connecting our family of software and apps
Our easy-to-use meters provide accurate results and reports for more meaningful insights
Explore the studies surrounding Flash Glucose Monitoring and the FreeStyle Libre systems for more details on study design, patient population and study outcomes.
Discover our library of educational modules, webinars and case studies for your peer to peer discussions.
Explore information and resources to help you support your patients.
Everything you need to know about the FreeStyle Libre systems and supporting your patients with diabetes, all in one place.
References & Disclaimers
Images are for illustrative purposes only. Not real patient, data, or healthcare professional.
^ FreeStyle Libre 2 and FreeStyle Libre 3 systems are part of the same family of products.
† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.
1. Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre portfolio compared to the number of users for other leading personal use sensor-based glucose monitoring systems.
2. Mark Evans, Zöe Welsh, Sara Ells, Alexander Seibold. “The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: a Meta-Analysis of Clinical Trials and Real-World Observational Studies.” Diabetes Therapy 11, no. 1 (2020):83–95. https://doi.org/10.1007/s13300-019-00720-0.
3. Marion Fokkert, Peter van Dijk, Mireille Edens, Eglantine Barents, Jeanine Mollema, Robert Slingerland, Reinhold Gans, Henk Bilo. “Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4).” BMJ Open Diabetes Research & Care 7, e000809 (2019). https://doi.org/10.1136/bmjdrc-2019-000809.
4. Lang J, Jangam S, Dunn T, Hayter G. Expanded real-world use reaffirms strong correlation between scanning frequency of flash glucose monitoring and glucose control [Poster 972]. Diabetes 2019 Jun; 68(Supplement 1).
5. Unger, J., Postgrad Med. (2020): https://doi.org/10.1080/00325481.2020.1744393.
6. Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603.
7. The Triangle of Diabetes Care developed by Dr. Ramzi Ajjan Associate Professor and Consultant in Diabetes and Endocrinology at the University of Leeds.
The "Yes" link below will take you to a website other than Abbott Laboratories. Links to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or any link contained in such websites. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.
Do you want to leave this page?
This is a product-specific website intended for HCPs of the European Union and the UK only. If you live in another country, please contact your local Abbott office to obtain the correct product information for your country of residence.